Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 297 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PINDOLOL | 15MG | TABLET | Resolved | 2023-06-19 | 2023-07-12 | 195533 |
| TEVA-PINDOLOL | 5MG | TABLET | Resolved | 2019-08-22 | 2021-06-03 | 92212 |
| TEVA-PINDOLOL | 5MG | TABLET | Resolved | 2021-07-29 | 2021-09-02 | 143265 |
| TEVA-PINDOLOL | 15MG | TABLET | Resolved | 2023-04-27 | 2023-07-05 | 190737 |
| TEVA-PINDOLOL | 15MG | TABLET | Resolved | 2021-06-10 | 2021-07-09 | 140672 |
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2021-03-18 | 2021-04-21 | 135971 |
| TEVA-PIROXICAM | 10MG | CAPSULE | Resolved | 2020-10-22 | 2020-11-07 | 126930 |
| TEVA-PIROXICAM | 10MG | CAPSULE | Resolved | 2018-03-13 | 2018-05-11 | 42570 |
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195903 |
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2023-10-19 | 2024-02-15 | 207435 |
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2022-10-17 | 2023-10-19 | 172024 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2022-05-19 | 2022-12-22 | 161003 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2022-06-03 | 2023-04-28 | 161964 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163927 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2023-10-05 | 2024-01-11 | 206395 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2021-04-21 | 2021-05-13 | 137893 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-05-20 | 2021-08-13 | 139737 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2024-05-03 | 2024-12-13 | 226936 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2024-05-09 | 2024-10-17 | 227468 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2024-06-07 | 2024-11-01 | 229948 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256146 |
| TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256149 |
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256152 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |